http://www.raredr.com/news/rnai-explained
RNAi Explained - A Conversation with Alnylam President, Barry Greene

James Radke, PhD



Barry Greene, President and COO of Alnylam Pharmaceuticals explains the technology behind the RNA interference (RNAi) therapies that the company have in development.

For more information, visit www.alnylam.com/
Printer Printing...
$content$